UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical trial results [MarketWatch]
Onconova Therapeutics, Inc. (ONTX)
Last onconova therapeutics, inc. earnings: 11/12 05:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.onconova.com/investor-overview
Company Research
Source: MarketWatch
UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical trial results Onconova Therapeutics Inc. ONTX, +7.77% stock surged 7% in morning trade Monday after the company said its drug had positive results in a mid-stage clinical trial for patients with higher-risk myelodysplastic syndromes, conditions that are considered a type of cancer. Patients in the trial weren't successfully treated with the standard of care, hypomethylating agents. Only about 40% to 50% of patients usually respond to that treatment, according to a 2015 scientific paper , and "outcome after HMA treatment failure is poor and represents an unmet need." Onconova Therapeutics' rigosertib's effect on bone marrow blast was tested as a proxy for overall survival, the company said, with patients demonstrating a reduction in the measure after treatment. These results from the trial, which treated 64 patients, are thus "a potential surrogate marker for improvement in overall survival in this patient
Show less
Read more
Impact Snapshot
Event Time:
ONTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONTX alerts
High impacting Onconova Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ONTX
News
- Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully [Yahoo! Finance]Yahoo! Finance
- Onconova Therapeutics' Rigosertib Poster Selected for AACR 2024 [Yahoo! Finance]Yahoo! Finance
- Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024GlobeNewswire
ONTX
Earnings
- 11/14/23 - Beat
ONTX
Sec Filings
- 3/15/24 - Form 4
- 3/15/24 - Form 4
- 3/14/24 - Form 144
- ONTX's page on the SEC website